Drug intelligence / Profile preview

orbitazine fumarate

Development stage
Phase 2
Lead developer
Shenzhen Zhenxing Pharmaceutical Technology
Modality
Small Molecules
Administration
Oral
01

Overview

Orbitazine fumarate (ZX-101) is a novel small-molecule tubulin inhibitor developed by Shenzhen Zhenxing Pharmaceutical Technology Co., Ltd. for the treatment of high-grade gliomas, including glioblastoma multiforme. It exerts its therapeutic effect by binding to the colchicine-binding site on tubulin, which inhibits microtubule polymerization and disrupts the formation of the mitotic spindle. This disruption leads to cell cycle arrest at the G2/M phase and induces apoptosis in rapidly proliferating tumor cells. Orbitazine is specifically designed to possess high blood-brain barrier permeability, addressing a major challenge in the treatment of primary central nervous system malignancies. It is currently being evaluated in clinical trials for patients with recurrent or refractory glioma.

Other names
orbitazine
02

Targets

TUBB (Tubulin (alpha and beta subunits))

Beyond the preview

Go deeper on orbitazine fumarate.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on orbitazine fumarate.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call